Literature DB >> 18039088

Acne vulgaris: lasers, light sources and photodynamic therapy--an update 2007.

Michael H Gold1.   

Abstract

Inflammatory acne vulgaris remains one of the most common dermatologic disorders seen in clinical practice. Medical therapy remains the gold standard for therapy but recent advances have shown that a variety of lasers and light sources may be useful in the treatment of inflammatory acne vulgaris. In addition, the use of 20% 5-aminolevulinic acid has found a useful niche in the treatment of moderate-to-severe inflammatory acne vulgaris.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18039088     DOI: 10.1586/14787210.5.6.1059

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  6 in total

Review 1.  Photodynamic therapy for prostate cancer--a review of current status and future promise.

Authors:  Caroline M Moore; Doug Pendse; Mark Emberton
Journal:  Nat Clin Pract Urol       Date:  2009-01

2.  Intense Pulsed light Versus 1,064 Long-Pulsed Neodymium: Yttrium-Aluminum- Garnet Laser in the Treatment of Facial Acne Vulgaris.

Authors:  Essam Elden Mohamed; Khaled Tawfik; Mohamed Elsaie
Journal:  J Clin Diagn Res       Date:  2016-07-01

3.  [Physical treatment methods for acne. Light, laser, photodynamic therapy and peeling].

Authors:  C Borelli; H C Korting
Journal:  Hautarzt       Date:  2010-02       Impact factor: 0.751

4.  Safety assessment of oral photodynamic therapy in rats.

Authors:  Carla R Fontana; Mark A Lerman; Niraj Patel; Clovis Grecco; Carlos A de Souza Costa; Mansoor M Amiji; Vanderlei S Bagnato; Nikolaos S Soukos
Journal:  Lasers Med Sci       Date:  2012-03-31       Impact factor: 3.161

5.  Acne vulgaris treatment : the current scenario.

Authors:  Sanjay K Rathi
Journal:  Indian J Dermatol       Date:  2011-01       Impact factor: 1.494

Review 6.  Photodynamic Therapy-Current Limitations and Novel Approaches.

Authors:  Gurcan Gunaydin; M Emre Gedik; Seylan Ayan
Journal:  Front Chem       Date:  2021-06-10       Impact factor: 5.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.